REG - PureTech Health PLC - Transaction in Own Shares
30/10/2023 07:15
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231030:nRSd6138Ra&default-theme=true
RNS Number : 6138R PureTech Health PLC 30 October 2023
30 October 2023
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has purchased the
following number of its ordinary shares of one pence each through Jefferies
International Limited ("Jefferies"), as part of its Share Buyback Programme,
details of which were announced on 9 May 2022.
Date of purchase: 27 October 2023
Number of ordinary shares purchased: 37,010
Highest price paid per share: 158.80p
Lowest price paid per share: 152.40p
Volume weighted average price paid per share: 155.40p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have 15,870,661 ordinary
shares in treasury and has 273,597,498 ordinary shares in issue (excluding
treasury shares). The total number of voting rights in the Company is
therefore 273,597,498 which may be used by shareholders in their calculations
to determine if they are required to notify their interest in, or a change to
their interest in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as
incorporated into UK domestic law by the European Union (Withdrawal) Act 2018)
(the Market Abuse Regulation), detailed information about the individual
purchases is available below.
About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to giving life
to new classes of medicine to change the lives of patients with devastating
diseases. The Company has created a broad and deep pipeline through its
experienced research and development team and its extensive network of
scientists, clinicians and industry leaders that is being advanced both
internally and through its Founded Entities. PureTech's R&D engine has
resulted in the development of 27 therapeutics and therapeutic candidates,
including two (Plenity® and EndeavorRx®) that have received both U.S.
FDA clearance and European marketing authorization and a third (KarXT) that
has been filed for FDA approval. A number of these programs are being advanced
by PureTech or its Founded Entities in various indications and stages of
clinical development, including registration enabling studies. All of the
underlying programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and then
advanced by the PureTech team through key validation points.
For more information, visit www.puretechhealth.com
(http://www.puretechhealth.com/) or connect with us on X, formerly known as
Twitter, @puretechh.
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
Individual Transactions
Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
27/10/2023 08:01:23 507 155 XLON 00375721589TRLO0.1.1
27/10/2023 08:01:23 448 155 CHIX 00375721588TRLO0.1.1
27/10/2023 08:01:23 6 155 XLON 00375721590TRLO0.1.1
27/10/2023 08:01:26 201 154.4 AQXE 00375721607TRLO0.1.1
27/10/2023 08:31:43 458 156.4 XLON 00375728714TRLO0.1.1
27/10/2023 08:31:43 55 156.6 XLON 00375728715TRLO0.1.1
27/10/2023 08:42:31 233 157.8 XLON 00375731209TRLO0.1.1
27/10/2023 08:42:31 232 158.2 XLON 00375731210TRLO0.1.1
27/10/2023 08:42:31 48 158.2 XLON 00375731211TRLO0.1.1
27/10/2023 10:03:57 95 158.2 CHIX 00375748773TRLO0.1.1
27/10/2023 10:03:57 19 158.2 CHIX 00375748772TRLO0.1.1
27/10/2023 10:03:57 495 158.2 CHIX 00375748774TRLO0.1.1
27/10/2023 10:03:57 232 158.2 CHIX 00375748775TRLO0.1.1
27/10/2023 10:03:57 201 158.2 AQXE 00375748776TRLO0.1.1
27/10/2023 10:03:57 55 158.2 CHIX 00375748778TRLO0.1.1
27/10/2023 10:03:57 201 158.2 AQXE 00375748777TRLO0.1.1
27/10/2023 10:03:59 291 158.8 XLON 00375748785TRLO0.1.1
27/10/2023 10:03:59 521 158.8 XLON 00375748784TRLO0.1.1
27/10/2023 10:04:39 94 158.8 XLON 00375748912TRLO0.1.1
27/10/2023 10:05:37 271 158.8 XLON 00375749193TRLO0.1.1
27/10/2023 10:06:12 350 158.8 XLON 00375749271TRLO0.1.1
27/10/2023 10:06:12 5 158 XLON 00375749272TRLO0.1.1
27/10/2023 10:08:45 56 158 BATE 00375749642TRLO0.1.1
27/10/2023 10:09:51 330 158 BATE 00375749867TRLO0.1.1
27/10/2023 10:09:51 386 158 BATE 00375749868TRLO0.1.1
27/10/2023 10:09:51 4224 158 XLON 00375749870TRLO0.1.1
27/10/2023 10:09:51 1021 158 XLON 00375749869TRLO0.1.1
27/10/2023 10:09:51 92 157.4 TRQX 00375749872TRLO0.1.1
27/10/2023 10:09:51 92 157.4 TRQX 00375749871TRLO0.1.1
27/10/2023 10:57:52 405 157.2 XLON 00375757689TRLO0.1.1
27/10/2023 11:11:04 121 157.2 XLON 00375759393TRLO0.1.1
27/10/2023 11:11:04 240 157.2 XLON 00375759394TRLO0.1.1
27/10/2023 11:25:50 136 157.4 BATE 00375761659TRLO0.1.1
27/10/2023 11:47:17 201 156.4 AQXE 00375763983TRLO0.1.1
27/10/2023 11:47:17 16 156.4 AQXE 00375763984TRLO0.1.1
27/10/2023 11:47:17 32 156.4 AQXE 00375763985TRLO0.1.1
27/10/2023 11:47:17 28 156.4 AQXE 00375763986TRLO0.1.1
27/10/2023 11:47:17 448 156.4 CHIX 00375763988TRLO0.1.1
27/10/2023 11:47:17 636 156.4 BATE 00375763987TRLO0.1.1
27/10/2023 11:47:17 32 156.4 CHIX 00375763989TRLO0.1.1
27/10/2023 11:47:17 1026 156.4 XLON 00375763990TRLO0.1.1
27/10/2023 11:47:22 92 156.4 TRQX 00375763996TRLO0.1.1
27/10/2023 11:49:30 365 155.6 XLON 00375764189TRLO0.1.1
27/10/2023 11:56:02 261 154.6 XLON 00375764913TRLO0.1.1
27/10/2023 12:02:46 353 154.6 XLON 00375765974TRLO0.1.1
27/10/2023 12:02:49 532 155.6 XLON 00375765979TRLO0.1.1
27/10/2023 12:02:49 180 155.6 XLON 00375765980TRLO0.1.1
27/10/2023 12:07:41 277 155.6 XLON 00375766531TRLO0.1.1
27/10/2023 12:12:04 42 154.6 TRQX 00375767220TRLO0.1.1
27/10/2023 12:12:39 319 154.6 XLON 00375767321TRLO0.1.1
27/10/2023 12:26:42 93 154.6 XLON 00375769214TRLO0.1.1
27/10/2023 12:26:42 219 154.6 XLON 00375769215TRLO0.1.1
27/10/2023 12:44:34 50 154.6 TRQX 00375771924TRLO0.1.1
27/10/2023 12:44:34 53 154.6 XLON 00375771925TRLO0.1.1
27/10/2023 12:44:34 280 154.6 XLON 00375771926TRLO0.1.1
27/10/2023 12:44:37 43 154.6 TRQX 00375771928TRLO0.1.1
27/10/2023 12:44:37 16 154.6 TRQX 00375771929TRLO0.1.1
27/10/2023 12:44:37 33 154.6 TRQX 00375771930TRLO0.1.1
27/10/2023 12:44:37 329 154.6 XLON 00375771931TRLO0.1.1
27/10/2023 12:44:37 222 154.6 XLON 00375771932TRLO0.1.1
27/10/2023 12:44:37 598 154.6 XLON 00375771933TRLO0.1.1
27/10/2023 12:44:37 61 154.2 CHIX 00375771934TRLO0.1.1
27/10/2023 12:44:37 36 154.2 CHIX 00375771935TRLO0.1.1
27/10/2023 12:44:37 43 154.2 CHIX 00375771936TRLO0.1.1
27/10/2023 12:44:40 276 154.2 CHIX 00375771945TRLO0.1.1
27/10/2023 12:44:40 49 154.2 CHIX 00375771946TRLO0.1.1
27/10/2023 12:44:40 131 154.2 CHIX 00375771948TRLO0.1.1
27/10/2023 12:59:53 75 154 BATE 00375774263TRLO0.1.1
27/10/2023 12:59:53 119 154 BATE 00375774264TRLO0.1.1
27/10/2023 13:29:32 53 154 XLON 00375779011TRLO0.1.1
27/10/2023 13:29:32 325 154 XLON 00375779012TRLO0.1.1
27/10/2023 13:34:20 280 154.8 XLON 00375780010TRLO0.1.1
27/10/2023 13:34:20 143 154.8 XLON 00375780011TRLO0.1.1
27/10/2023 14:22:54 136 155.6 AQXE 00375789842TRLO0.1.1
27/10/2023 14:30:06 312 154.6 CHIX 00375791970TRLO0.1.1
27/10/2023 14:30:07 190 155.6 AQXE 00375792052TRLO0.1.1
27/10/2023 14:34:16 130 154.6 CHIX 00375795669TRLO0.1.1
27/10/2023 14:34:16 67 154.6 CHIX 00375795671TRLO0.1.1
27/10/2023 14:34:16 197 154.6 CHIX 00375795670TRLO0.1.1
27/10/2023 14:34:16 386 154.6 BATE 00375795672TRLO0.1.1
27/10/2023 14:34:16 1026 154.6 XLON 00375795673TRLO0.1.1
27/10/2023 14:35:19 907 154 XLON 00375796273TRLO0.1.1
27/10/2023 14:35:19 240 154 XLON 00375796275TRLO0.1.1
27/10/2023 14:35:19 201 154.4 AQXE 00375796274TRLO0.1.1
27/10/2023 14:35:19 356 154 XLON 00375796276TRLO0.1.1
27/10/2023 14:54:32 386 154 BATE 00375807686TRLO0.1.1
27/10/2023 14:54:32 36 154 XLON 00375807685TRLO0.1.1
27/10/2023 14:54:32 1503 154 XLON 00375807687TRLO0.1.1
27/10/2023 14:54:32 302 153.8 XLON 00375807688TRLO0.1.1
27/10/2023 14:54:32 211 153.8 XLON 00375807689TRLO0.1.1
27/10/2023 14:54:33 92 153.4 TRQX 00375807690TRLO0.1.1
27/10/2023 14:54:33 2 153.4 TRQX 00375807691TRLO0.1.1
27/10/2023 14:54:33 3 153.4 TRQX 00375807692TRLO0.1.1
27/10/2023 14:54:34 87 153.4 TRQX 00375807712TRLO0.1.1
27/10/2023 14:56:56 989 152.4 XLON 00375808685TRLO0.1.1
27/10/2023 14:56:58 359 152.4 XLON 00375808714TRLO0.1.1
27/10/2023 15:01:59 133 152.6 CHIX 00375811299TRLO0.1.1
27/10/2023 15:02:03 159 152.6 CHIX 00375811385TRLO0.1.1
27/10/2023 15:14:41 78 153.4 XLON 00375817601TRLO0.1.1
27/10/2023 15:16:25 110 153.4 XLON 00375818478TRLO0.1.1
27/10/2023 15:16:25 838 153.4 XLON 00375818479TRLO0.1.1
27/10/2023 15:16:29 220 153.2 BATE 00375818548TRLO0.1.1
27/10/2023 15:16:29 201 153.2 AQXE 00375818547TRLO0.1.1
27/10/2023 15:22:04 107 153.2 BATE 00375821055TRLO0.1.1
27/10/2023 15:24:46 438 153.2 XLON 00375822357TRLO0.1.1
27/10/2023 15:24:46 59 153.2 BATE 00375822358TRLO0.1.1
27/10/2023 15:24:46 192 153.2 BATE 00375822359TRLO0.1.1
27/10/2023 15:24:46 293 153.2 BATE 00375822360TRLO0.1.1
27/10/2023 15:24:46 416 153.2 XLON 00375822363TRLO0.1.1
27/10/2023 15:24:46 172 153.2 XLON 00375822364TRLO0.1.1
27/10/2023 15:24:46 92 153 TRQX 00375822365TRLO0.1.1
27/10/2023 15:24:46 32 153 TRQX 00375822366TRLO0.1.1
27/10/2023 15:29:23 401 153.2 XLON 00375824227TRLO0.1.1
27/10/2023 15:29:23 189 153.2 XLON 00375824228TRLO0.1.1
27/10/2023 15:42:06 535 154.4 XLON 00375830251TRLO0.1.1
27/10/2023 15:52:16 173 154.6 XLON 00375834930TRLO0.1.1
27/10/2023 16:14:07 1026 154.2 XLON 00375844986TRLO0.1.1
27/10/2023 16:14:07 1026 154.2 XLON 00375844987TRLO0.1.1
27/10/2023 16:14:07 448 153.8 CHIX 00375844988TRLO0.1.1
27/10/2023 16:14:07 513 153.6 XLON 00375844989TRLO0.1.1
27/10/2023 16:14:08 238 153.2 BATE 00375844999TRLO0.1.1
27/10/2023 16:20:01 170 154.8 CHIX 00375848403TRLO0.1.1
27/10/2023 16:25:55 89 154.8 CHIX 00375850921TRLO0.1.1
27/10/2023 16:29:02 55 154.8 XLON 00375852543TRLO0.1.1
27/10/2023 16:29:44 1 155.6 BATE 00375853032TRLO0.1.1
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSFLFFDIVLDFIVRecent news on Puretech Health
See all newsREG - PureTech Health PLC - Total Voting Rights
AnnouncementREG - PureTech Health PLC - Final Results
AnnouncementREG - PureTech Health PLC - Notice of Results
AnnouncementRCS - PureTech Health PLC - PRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
AnnouncementRCS - PureTech Health PLC - FDA Grants PRTC's LYT-200 Fast Track Designation
Announcement